Ami Fadia
Stock Analyst at Needham
(4.57)
# 216
Out of 5,067 analysts
404
Total ratings
53.15%
Success rate
26.63%
Average return
Main Sectors:
Stocks Rated by Ami Fadia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $42 | $34.57 | +21.49% | 39 | Nov 24, 2025 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $16 | $8.51 | +88.01% | 22 | Nov 24, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $66 → $72 | $72.45 | -0.62% | 27 | Nov 6, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Buy | $28 → $29 | $23.54 | +23.19% | 12 | Nov 6, 2025 | |
| AXSM Axsome Therapeutics | Reiterates: Buy | $154 | $149.22 | +3.20% | 17 | Nov 4, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $170 → $184 | $140.99 | +30.51% | 16 | Oct 29, 2025 | |
| ALKS Alkermes | Maintains: Buy | $43 → $44 | $28.30 | +55.48% | 4 | Oct 29, 2025 | |
| NMRA Neumora Therapeutics | Maintains: Buy | $6 → $8 | $2.28 | +250.88% | 10 | Oct 28, 2025 | |
| AVDL Avadel Pharmaceuticals | Downgrades: Hold | n/a | $23.15 | - | 37 | Oct 22, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $80 → $250 | $171.14 | +46.08% | 13 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $14.05 | +35.23% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $3.85 | +212.09% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $10.90 | +156.88% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.25 | +51.72% | 20 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $96 | $95.94 | +0.06% | 31 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $182.05 | - | 43 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $202 | $179.97 | +12.24% | 34 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $38.50 | - | 23 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $29.12 | +20.19% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $6.59 | +340.06% | 21 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $240 → $320 | $16.50 | +1,839.39% | 2 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $63 → $75 | $23.16 | +223.83% | 7 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $15 → $23 | $0.42 | +5,233.02% | 4 | Oct 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $63 | $12.46 | +405.62% | 5 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $24.58 | - | 9 | Oct 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $22 | $1.09 | +1,918.35% | 4 | Jan 3, 2018 |
Harmony Biosciences Holdings
Nov 24, 2025
Reiterates: Buy
Price Target: $42
Current: $34.57
Upside: +21.49%
Day One Biopharmaceuticals
Nov 24, 2025
Reiterates: Buy
Price Target: $16
Current: $8.51
Upside: +88.01%
Revolution Medicines
Nov 6, 2025
Maintains: Buy
Price Target: $66 → $72
Current: $72.45
Upside: -0.62%
ACADIA Pharmaceuticals
Nov 6, 2025
Maintains: Buy
Price Target: $28 → $29
Current: $23.54
Upside: +23.19%
Axsome Therapeutics
Nov 4, 2025
Reiterates: Buy
Price Target: $154
Current: $149.22
Upside: +3.20%
Neurocrine Biosciences
Oct 29, 2025
Maintains: Buy
Price Target: $170 → $184
Current: $140.99
Upside: +30.51%
Alkermes
Oct 29, 2025
Maintains: Buy
Price Target: $43 → $44
Current: $28.30
Upside: +55.48%
Neumora Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $2.28
Upside: +250.88%
Avadel Pharmaceuticals
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $23.15
Upside: -
Praxis Precision Medicines
Oct 16, 2025
Maintains: Buy
Price Target: $80 → $250
Current: $171.14
Upside: +46.08%
Oct 13, 2025
Initiates: Buy
Price Target: $19
Current: $14.05
Upside: +35.23%
Oct 13, 2025
Initiates: Buy
Price Target: $12
Current: $3.85
Upside: +212.09%
Oct 13, 2025
Initiates: Buy
Price Target: $28
Current: $10.90
Upside: +156.88%
Sep 30, 2025
Reiterates: Buy
Price Target: $11
Current: $7.25
Upside: +51.72%
Sep 29, 2025
Downgrades: Hold
Price Target: $96
Current: $95.94
Upside: +0.06%
Sep 24, 2025
Reiterates: Hold
Price Target: n/a
Current: $182.05
Upside: -
Aug 28, 2025
Reiterates: Buy
Price Target: $202
Current: $179.97
Upside: +12.24%
Jun 17, 2025
Reiterates: Hold
Price Target: n/a
Current: $38.50
Upside: -
May 28, 2025
Initiates: Buy
Price Target: $35
Current: $29.12
Upside: +20.19%
May 2, 2025
Reiterates: Buy
Price Target: $29
Current: $6.59
Upside: +340.06%
Feb 1, 2021
Maintains: Outperform
Price Target: $240 → $320
Current: $16.50
Upside: +1,839.39%
Jan 21, 2021
Downgrades: Market Perform
Price Target: $63 → $75
Current: $23.16
Upside: +223.83%
Oct 1, 2020
Maintains: Market Perform
Price Target: $15 → $23
Current: $0.42
Upside: +5,233.02%
Sep 17, 2020
Maintains: Outperform
Price Target: $64 → $63
Current: $12.46
Upside: +405.62%
Oct 1, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $24.58
Upside: -
Jan 3, 2018
Initiates: Outperform
Price Target: $22
Current: $1.09
Upside: +1,918.35%